CRISPR Therapeutics AG (CRSP) Minority Interest (2015 - 2016)
CRISPR Therapeutics AG's (CRSP) quarterly Minority Interest came in at -$51000.0 in Q3 2016, down 88.89% quarter-over-quarter from -$27000.0 in Q4 2015.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Minority Interest (2015 - 2016) Analysis & Trends
CRISPR Therapeutics AG has disclosed Minority Interest across 2 years of filings, most recently posting -$51000.0 for Q3 2016.
- In Q3 2016, Minority Interest changed N/A year-over-year to -$51000.0; the TTM figure through Sep 2016 stood at -$51000.0 (changed N/A YoY), while the FY2015 annual figure was -$27000.0, changed N/A from the prior year.
- Minority Interest came in at -$51000.0 for Q3 2016 at CRISPR Therapeutics AG, down from -$27000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of -$27000.0 in Q4 2015 to a low of -$51000.0 in Q3 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - |